Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|24|3|420-427

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.24, Iss.3, 2018-03, pp. : 420-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 2, 2018-02 ,pp. : 193-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous ablative treatments of hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1465-1466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 934-942

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 378-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status of Stereotactic Biopsy

By  

Stereotactic and Functional Neurosurgery, Vol. 76, Iss. 3-4, 2002-09 ,pp. : 137-139

Karger

Access to resources Recommend Favorite